Form 4: Alkermes EVP Craig Hopkinson Reports Share Acquisition and Disposal
SEC Form 4 Filing
EVP and Chief Medical Officer of Alkermes, Craig C. Hopkinson, reports acquisition of shares through vesting of restricted stock units and subsequent disposal to cover tax obligations.
Summary
- Craig C. Hopkinson, EVP and Chief Medical Officer of Alkermes, reported transactions involving Alkermes plc. ordinary shares on February 6, 2025.
- Hopkinson acquired 34,393 ordinary shares through the vesting of performance-vesting restricted stock units (PRSUs) granted on February 18, 2022.
- These PRSUs had a three-year performance period ending on December 31, 2024, with vesting contingent on achieving pre-specified performance goals and a total shareholder return modifier.
- Concurrently, Hopkinson disposed of 15,083 shares at a price of $31.39 to satisfy tax obligations related to the vesting of the PRSUs.
- Following these transactions, Hopkinson beneficially owns 63,600 Alkermes ordinary shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by an executive. The vesting of PRSUs is a positive signal, but the subsequent sale to cover taxes is a standard practice.
Positives
- The vesting of performance-based restricted stock units suggests that Alkermes achieved certain pre-specified performance goals.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track executive compensation and potential alignment of interests.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax-related sales.
Key Dates
| Date | Description |
|---|---|
| 2022/02/18 | Date of grant for the performance-vesting restricted stock unit awards (PRSUs). |
| 2024/12/31 | End date of the three-year performance period for the 2022 PRSUs. |
| 2025/02/06 | Date of the reported transactions: acquisition and disposal of shares. |
| 2025/02/07 | Date of signature for the Form 4 filing. |
Keywords
Alkermes, Hopkinson, share disposal, share acquisition, Form 4, restricted stock units, performance vesting, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.